Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis

Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers

(2020) Feriel Azibani et al.   ESC Heart Failure

Peripartum cardiomyopathy

(2019) Michael C Honigberg et al.   BMJ-British Medical Journal

Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy

(2019) Johann Bauersachs et al.   EUROPEAN JOURNAL OF HEART FAILURE

Long‐term follow‐up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co‐morbidities

(2019) Valeska Moulig et al.   EUROPEAN JOURNAL OF HEART FAILURE

Predictors of early and delayed recovery in peripartum cardiomyopathy: A prospective study of 52 patients

(2018) Murat Biteker et al.   Journal of Maternal-Fetal & Neonatal Medicine

The prognostic significance of the 12-lead ECG in peripartum cardiomyopathy

(2018) J. Hoevelmann et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study

(2017) Denise Hilfiker-Kleiner et al.   EUROPEAN HEART JOURNAL

Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM)

(2017) Karen Sliwa et al.   EUROPEAN JOURNAL OF HEART FAILURE

Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey

(2015) N Bernard et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy

(2015) Arash Haghikia et al.   Clinical Research in Cardiology

Analysis of changes in maternal circulating angiogenic factors throughout pregnancy for the prediction of preeclampsia

(2015) M C Honigberg et al.   Journal of Perinatology

Clinical Outcomes for Peripartum Cardiomyopathy in North America

(2015) Dennis M. McNamara et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Correlation between Peripartum Cardiomyopathy and Autoantibodies against Cardiovascular Receptors

(2014) Jiamei Liu et al.   PLoS One

Temporal Trends in Incidence and Outcomes of Peripartum Cardiomyopathy in the United States: A Nationwide Population‐Based Study

(2014) Dhaval Kolte et al.   Journal of the American Heart Association

Differences in Clinical Profile of African-American Women With Peripartum Cardiomyopathy in the United States

(2013) Sorel Goland et al.   JOURNAL OF CARDIAC FAILURE

Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum Cardiomyopathy

(2010) Karen Sliwa et al.   CIRCULATION

Rare Variant Mutations in Pregnancy-Associated or Peripartum Cardiomyopathy

(2010) Ana Morales et al.   CIRCULATION

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

(2010) Andreas Stang   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy

(2010) Karen Sliwa et al.   EUROPEAN JOURNAL OF HEART FAILURE

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE